You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Liver conditions
  5. Chronic liver disease

Obeticholic acid for treating primary biliary cholangitis

  • Technology appraisal guidance
  • Reference number: TA443
  • Published:  26 April 2017
  • Guidance
  • Tools and resources
  • Information for the public
  • History

On this page

  1. Final appraisal determination
  2. Invitation to participate
  3. Draft scope documents

History

Documents created during the development process.

Final appraisal determination

  • Final appraisal determination

  • Final appraisal determination document (PDF 418 KB)

    Published:
    02 March 2017
  • Public committee slides clinical cost effectiveness (PDF 789 KB)

    Published:
    02 March 2017
  • Public committee slides cost effectiveness (PDF 333 KB)

    Published:
    02 March 2017
  • Committee papers FAD papers (PDF 11.42 MB)

    Published:
    08 March 2017

Invitation to participate

  • Final scope (PDF 99 KB)

    Published:
    08 August 2016
  • Final matrix (PDF 98 KB)

    Published:
    08 August 2016
  • NICE's response to comments on the draft scope and provisional matrix (PDF 244 KB)

    Published:
    08 August 2016
  • Equality impact assessment (Scoping) (PDF 122 KB)

    Published:
    08 August 2016

Draft scope documents

  • Draft scope (pre-referral) (PDF 106 KB)

    Published:
    27 November 2015
  • Provisional matrix (pre-referral) (PDF 98 KB)

    Published:
    27 November 2015
Back to top